In a research report released this morning, Cantor analyst Irina Rivkind upgraded shares of Endo Health Solutions (NASDAQ:ENDP) to Hold from Sell, with a $56 price target, …
In a special research report released today, Cantor Fitzgerald analyst Youssef Squali initiated a Buy rating on Alibaba Group (NYSE:BABA) with a $90 price target, ahead …
In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Hold rating on Ligand Pharmaceuticals (LGND) and raised her price target to $49 (from $45), as her big picture …
In a research report released today, Cantor Fitzgerald analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (SGYP), with a $11 price target. The report follows the company’s …
Strength across all major Expedia (EXPE) brands as well as better-than-expected performance of the Travelocity partnership contributed to solid 2Q results that were …
